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Abstract
Background: the primary objective was to develop an adjective checklist, the Fatigue Quality List
(FQL), aimed at assessing different perceptions of fatigue.
Methods: 961 participants filled out the FQL (28 adjectives). A component and confirmatory
factor analyses were performed and psychometric properties were evaluated. Differences on
factor scores between different patients' groups were investigated and pre- and post treatment
scores were compared in demonstrating change of perceptions after treatment of fatigue.
Results: Four independent factors were found with adequate psychometric properties. Different
perceptions were found between the patients' groups. Patients who were recovered after
treatment for fatigue showed similar scores on the factors as healthy controls.
Conclusion: The FQL appears to be a promising tool in measuring different perceptions of fatigue,
which can be especially interesting for clinical practice.
Background
What is meant by fatigue? Most people are familiar with
the experience of fatigue, but the meaning of this sensa-
tion can differ between people and even within one per-
son the meaning of fatigue can change. Therefore, fatigue
can be defined in different ways and there is no 'gold
standard'. Healthy people would characterise fatigue as a
pleasant, acute, normal and regulating phenomenon after
exercise or a busy day, disappearing after a good night's
sleep or a period of rest. However, fatigue can also have a
more negative connotation as in fatigue experienced by
patients with a health problem. To them fatigue can be a
chronic, disabling and life- and activity-limiting experi-
ence [1-6].
There are also differences in the factors underlying fatigue
severity between patients with different somatic condi-
tions. Processes involved in the experience of fatigue in
patients with chronic fatigue syndrome (CFS) are clearly
different from processes related to the experience of
fatigue in patients with multiple sclerosis (MS) [2] and
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there are many differences between severely fatigued
breast cancer survivors and females with CFS [7].
Because fatigue is not clearly defined, poor communica-
tion regarding fatigue exist in the clinical practice [8].
Additionally, health care professionals find consultations
on fatigue difficult and are often dissatisfied with or
uncertain about the care they provide to patients with
fatigue complaints [9,10]. Without appropriate assess-
ment, recognition and providing the proper management
to patients with chronic fatigue is difficult. The first neces-
sary step towards improving recognition and manage-
ment is a thorough understanding of the symptom.
Until now fatigue scales are mostly used to measure
fatigue severity [11]. However, fatigue severity does not
reflect a persons' perception and appraisal of the fatigue.
Therefore, the quantitative way of assessing fatigue fails to
capture the nuances and differences in the experience of
fatigue. In pain research assessment methods already
exists in determining the quality of pain in a patient by
using adjectives [12,13].
In this study an adjective checklist, the Fatigue Quality List
(FQL), was constructed aimed at assessing different per-
ceptions of fatigue. The development of the FQL was
described and additionally three research questions were
investigated:
1. Is the FQL a reliable and valid instrument to assess dif-
ferent perceptions of fatigue?
2. Are perceptions of fatigue different between several
patient groups with and without chronic fatigue com-
plaints and healthy controls?
3. Do perceptions of fatigue change in patients who
recover after treatment for fatigue?
Methods
Materials
Fatigue Quality List
Researchers and clinicians working at the Expert Centre
Chronic Fatigue of the Radboud University Nijmegen
Medical Centre made a large list of all possible adjectives
that can be used to characterize the feeling of fatigue. The
FQL was developed by asking researchers and health care
professionals working with patients with unexplained
fatigue complaints to indicate on this large list which of
the adjectives best fitted with the experience of the fatigue
described by their patients. The final list consisted of 28
adjectives most frequently mentioned by the raters.
In filling out the FQL, subjects are instructed to mark with
a cross which of the 28 adjectives fit their experienced
fatigue. Multiple answers are possible. In this study the
Dutch version of the FQL was used. However, the adjec-
tives were translated into English by a back-translation
procedure.
Fatigue severity was measured by a subscale of the Check-
list Individual Strength (CIS-fatigue) consisting of 8 items
[14]. Each item was scored on a 7-point Likert scale. High
scores indicated a high level of fatigue severity. Based on
research with Chronic Fatigue Syndrome patients, a score
of 35 or higher on the subscale fatigue severity indicated
severe feelings of fatigue. Furthermore, the CIS has excel-
lent psychometric properties [1,11].
Patients
Nine-hundred-sixty-one participants with a mean age of
43.6 years (sd = 10.2, range 18–79) predominantly female
(65%) filled out the FQL. All were either patients or
healthy controls participating in scientific studies con-
ducted by the Expert Centre Chronic Fatigue. The total
group consisted of:
- 219 cancer survivors. Hundred-twenty-eight (mean age
44.8 (sd = 8.9); female 72%) experienced severe chronic
fatigue and 91 (mean age 46.5 (sd = 6.3); female 100%)
were not fatigued [3]. Forty-one of these cancer survivors
were participating in a randomised control trial about the
effectiveness of cognitive behaviour therapy (CBT) espe-
cially designed to reduce chronic fatigue in cancer survi-
vors [15]. These patients filled out the FQL at pre- and
post treatment.
- 160 patients who were diagnosed with Chronic Fatigue
Syndrome (CFS), according to the CDC criteria (mean age
38.0 (sd = 10.7); female 69%) [4,16]. Eighty-two CFS
patients who were included in this study were treated for
their chronic fatigue complaints with CBT [4]. These
patients filled out the FQL two times, at pre- and post
treatment.
- 151 employees on sick leave with unexplained fatigue
complaints (mean age 44.0 (sd = 8.4); female 55%) [17].
66 (44%) of these met research criteria for CFS (mean age
42.9 (sd = 8.6); female 61%).
- 276 patients with various neuromuscular disorders.
Hundred-sixty-five experienced severe fatigue (mean age
42.2 (sd = 10.6); female 48%) and 120 experienced no
fatigue complaints (mean age 42.2 (sd = 11.3); female
48%) [5,18]
- 77 patients who were diagnosed with pancreatitis. Fifty-
three experienced severe fatigue (mean age 49.3 (10.0);
female 47%) and 24 were not fatigued (mean age 50.2 (sd
= 15.5); female 58%).Health and Quality of Life Outcomes 2007, 5:36 http://www.hqlo.com/content/5/1/36
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- 78 healthy persons who experienced no fatigue com-
plaints (mean age 48.2 (6.2); female 100%) [3].
Statistical analysis
Data analysis was performed using SPSS (version 12.0.1).
The total participant group was randomly divided into
two groups. A principal component factor analysis was
performed in the first group to identify independent fac-
tors. A varimax rotation was used to facilitate the interpre-
tation. Furthermore, factor loadings had to be above .40
with a .10 or greater difference in loadings with the other
factors. The scree test and the eigenvalues (above 1) were
used to identify the number of factors. The factor model
was then tested in the second group by using confirmatory
factor analyses/AMOS 5.0 (Comparative Fit Index, Good-
ness of Fit Index, Adjusted Goodness of Fit Index [19,20]).
The internal consistency reliability for each factor was cal-
culated using Cronbach's alpha. Spearman's rho correla-
tions were used to evaluate psychometric properties of the
FQL. To investigate the differences between the groups of
patients Kruskal-Wallis tests were performed. When the
Kruskal-Wallis test was significant, Mann-Whitney-U tests
between the groups followed. The sensitivity to change of
the FQL was demonstrated by comparing cancer survivors
and CFS patients at pre- and post treatment assessment,
using the Wilcoxon Signed Ranks Test of matched pairs.
To correct for the multiple comparisons, p-value was set
on < 0.01.
Results
Factor solution
Three of the 28 adjectives were marked with a cross for less
than 10% and therefore excluded from further analyses.
Final analyses were done with the remaining 25 adjec-
tives. Table 1 presents the final factor solution in the first
group (n = 476). Seven adjectives were excluded of factor
analysis because factor loadings were < .40 and/or <.10
difference in loadings with the other factors. Both the
scree test and eigenvalues indicated a 4-factor solution
(Table 2). Factor 1 consisted of 5 adjectives, factor 2 of 4
adjectives, factor 3 of 5 adjectives and factor 4 of 4 adjec-
tives, explaining respectively, 24%, 9%, 6%, 5% of the var-
iance prior to rotation. After rotation the four factors
explained respectively, 13%, 12%, 10% and 9% of the var-
iance. Factor 1 was labelled as 'Frustrating', Factor 2 as
'Exhausting', Factor 3 as 'Pleasant' and Factor 4 as 'Fright-
ening'. This four factor model was then tested in the sec-
ond group (n = 485) by using confirmatory factor
analysis. The fit indices indicated an adequate fit. Chi-
square (129, n = 485) = 364.5, p < 0.001; Comparative Fit
Index = .87; Goodness of Fit Index = .92; Adjusted Good-
ness of Fit Index = .90.
The four factors were recoded on a 0 to 100 scale, facilitat-
ing comparisons between the factors. Higher scores indi-
Table 2: principal-components analysis with varimax-rotation, 
initial eigenvalues
component Eigenvalues
1 4.788
2 1.906
3 1.285
4 1.176
5 0.984
6 0.875
7 0.813
8 0.742
9 0.714
10 0.664
11 0.623
12 0.593
13 0.568
14 0.514
15 0.503
16 0.445
17 0.428
18 0.380
Table 1: Final factor solution: principal-components analysis with 
varimax-rotation in the first group. Cronbach's Alpha of the four 
factors
Frustrating Exhausting Pleasant Frightening
discouraging .735
incessant .585
annoying .680
persistent .559
frustrating .704
exhausting .690
wearisome .537
extreme .724
unbearable .509
temporary .400
relaxing .661
fulfilling .713
normal .522
pleasant .792
upsetting .727
frightening .618
inexplicable .490
insuperable .444
Cronbach's 
Alpha
.79 .68 .61 .57
Three adjectives were excluded of factor analysis because they were 
marked with a cross for less than 10%: Protective, Soothing, 
Threatening. Seven adjectives were excluded of factor analysis 
because factor loadings <.40 and/or <.10 difference in loadings with 
the other factors: Demanding, Paralysing, Aggravating, Compelling, 
Treacherous, Insoluble, AcceptableHealth and Quality of Life Outcomes 2007, 5:36 http://www.hqlo.com/content/5/1/36
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cate a higher appraisal of the fatigue experience as
frustrating, exhausting, pleasant and frightening. The final
version of the FQL and the criteria for scoring are pre-
sented in appendix A.
Is the FQL a reliable and valid instrument to assess 
different perceptions of fatigue?
For each factor the internal consistency reliability was calcu-
lated in the entire sample of 961 participants, which dem-
onstrated moderate to adequate internal consistencies for
all four factors, ranging from .57 to .79 (Table 1).
Supporting convergent validity we found that all four fac-
tors were statistically significant related to fatigue severity
(CIS-fatigue) (Table 3).
In calculating general psychometric properties statistically
significant intercorrelations between the four factors were
found (Table 3). Additionally, low correlations were
found between the four factors and age and gender,
explaining less than 3% of the variance.
Are the perceptions of fatigue different between several 
patient groups with and without chronic fatigue 
complaints and healthy controls?
The non-fatigued groups scored significantly lower on
Frustrating, Exhausting and Frightening and significantly
higher on Pleasant compared with the fatigued groups
(Table 4). The following analyses were performed sepa-
rately in the fatigued groups and the non-fatigued groups.
Frustrating
The non-fatigued groups were similar with respect to the
mean scores on Frustrating (p = 0.757). Patients with
chronic fatigue syndrome and employees with unex-
plained fatigue scored significantly higher on Frustrating
with respect to the other fatigued groups.
Exhausting
The non-fatigued patients with various neuromuscular
disorders scored significantly lower on Exhausting than
the non-fatigued cancer survivors and the non-fatigued
patients with pancreatitis. Between the fatigued groups,
CFS patients scored significantly higher on Exhausting
than the other groups. Furthermore, fatigued patients
with pancreatitis scored significantly lower with respect to
fatigued cancer survivors and employees with unex-
plained fatigue. Additionally, patients with neuromuscu-
lar disorders scored significantly lower than employees
with unexplained fatigue.
Pleasant
In the non-fatigued group patients with various neu-
romuscular disorders scored significantly lower on Pleas-
Table 4: Mean score on 4 factors: comparisons between fatigued disease-free cancer patients, CFS patients, employees with 
unexplained fatigue, fatigued patients with neuromuscular disease, fatigued patients with pancreatitis, non-fatigued disease-free 
cancer patients, non-fatigued patients with neuromuscular disease, non-fatigued patients with pancreatitis and healthy persons
Frustrating Exhausting Pleasant Frightening
A. Fatigued disease-free cancer patients 48.6 (30.9)b,c 29.3 (28.6)b,d 11.7 (17.7)b,c 22.7 (24.2)d,e
B. Chronic fatigue syndrome 58.5 (32.2)a,d,e 37.8 (31.5)a,c,d,e 6.6 (13.0)a,c,d 25.2 (25.9)d,e
C. Employees with unexplained fatigue 63.7 (29.2)a,d,e 29.5 (28.1)b,d 4.3 (11.2)a,b,d,e 26.0 (26.6)d,e
D. Fatigued patients with neuromuscular disease 41.8 (32.6)b,c 17.8 (24.8)a,b,c 13.6 (18.5)b,c 13.8 (20.1)a,b,c
E. Fatigued patients with pancreatitis 41.1 (33.1)b,c 25.9 (29.8)b 9.1 (13.9)c 14.2 (22.7)a,b,c
F. Non-fatigued disease-free cancer patients 8.1 (16.3) 6.6 (14.4)g 38.9 (28.3)g 7.7 (17.0)
G. Non fatigued patients with neuromuscular disease 9.0 (16.2) 1.7 (7.1)f,h 24.7 (21.3)f,I 5.6 (13.9)
H. Non-fatigued patients with pancreatitis 13.3 (28.1) 9.4 (17.8)g 29.2(23.6) 5.2 (12.7)
I. Healthy persons 7.7 (18.3) 3.9 (13.4) 36.2 (23.3)g 3.2 (10.2)
a. significantly different from group A, Mann-Whitney test p < 0.01
b. significantly different from group B, Mann-Whitney test p < 0.01
c. significantly different from group C, Mann-Whitney test p < 0.01
d. significantly different from group D, Mann-Whitney test p < 0.01
e. significantly different from group E, Mann-Whitney test p < 0.01
f. significantly different from group F, Mann-Whitney test p < 0.01
g. significantly different from group G, Mann-Whitney test p < 0.01
h. significantly different from group H, Mann-Whitney test p < 0.01
i. significantly different from group I, Mann-Whitney test p < 0.01
Table 3: Convergent validity of the 4 factors. Spearman's rho 
correlation in total group (N = 961)
Factor Frustrating Exhausting Pleasant Frightening
Fatigue 
Severity
.66* .58* -.54* .43*
Exhausting .54*
Pleasant -.48* -.35*
Frightening .49* .42* -.25*
Age -.16* -.14* .05 -.03
Gender 
(1 = M, 2 = F)
-.09* .03 .11* -.10*
* p < 0.01Health and Quality of Life Outcomes 2007, 5:36 http://www.hqlo.com/content/5/1/36
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ant than non-fatigued cancer survivors and healthy
persons. In the fatigued group employees with unex-
plained fatigue scored significantly lower on Pleasant
than the other groups. CFS patients scored significantly
lower than cancer survivors and patients with neuromus-
cular disorders.
Frightening
The scores on Frightening in the non-fatigued groups were
similar. In the fatigued groups a dichotomy was found
between the patients with unexplained fatigue with and
without a chronic disease. Fatigued patients without a
chronic disease (cancer survivors, CFS patients and
employees) scored significantly higher on Frightening
than fatigued patients with a chronic disease (patients
with a neuromuscular disorder or pancreatitis).
Do perceptions of fatigue change in patients who recover 
after treatment for fatigue?
Forty-one fatigued cancer survivors and eighty-two CFS
patients were treated for their fatigue complaints with CBT
at our department and filled out the FQL at pre- and post
treatment. Sensitivity to change of the FQL was demon-
strated by dividing the CFS patients and the cancer survi-
vors into two groups: patients who were completely
recovered after CBT (CIS-fatigue < 35) and patients who
remained fatigued after CBT (CIS-fatigue >= 35). Baseline
scores on the four factors were not significantly different
between patient who recovered and patients who
remained fatigued. The scores on the four factors at pre-
and post treatment were compared. Additionally, we com-
pared the post treatment scores on the four factors with
the scores of healthy individuals (Table 5). Cancer survi-
vors who were completely recovered after CBT (n = 27)
showed a significant decrease on the factors Frustrating,
Exhausting and Frightening and a significant increase on
the factor Pleasant.
The post-treatment scores were not significantly different
from those of healthy individuals. In contrast, the cancer
survivors who still remained fatigued after CBT (n = 14)
did not show a change in the scores on the four factors
from pre- to post treatment. Furthermore, their scores at
post treatment were significantly different from the scores
of healthy individuals. In investigating CFS patients who
recovered after CBT (n = 47) the same pattern was found.
They also decreased significantly on the factors Frustrat-
ing, Exhausting and Frightening and increased signifi-
cantly on the factor Pleasant. The scores at post treatment
were not significantly different from those of healthy indi-
viduals. CFS patients who were not recovered after CBT (n
= 35) showed no change between pre- and post treatment
scores on the factors Frustrating, Exhausting and Pleasant.
Although a significant decrease was seen on the factor
Frightening, the post treatment scores of the four factors
were significantly different form those of healthy individ-
uals.
Discussion
The present study shows that the FQL provides a self
report instrument that assesses the perceptions of fatigue.
The FQL consists of four coherent factors, namely Frustrat-
ing, Exhausting, Pleasant and Frightening. The stable pat-
tern of these factors was indicated with a confirmatory
factor analyses, revealing an invariant internal structure in
a second group of patients. Furthermore, the data of this
Table 5: Comparison of pre- and post treatment scores on the four factors. Comparison of the post treatment scores with those of 
healthy individuals
Frustrating Exhausting  Pleasant Frightening
Cancer survivors
A non fatigued after CBT (n = 27) pre-treatment 52.6 (27.8) 27.8 (24.4) 11.1 (14.0) 22.2 (23.3)
post-treatment 11.9 (23.0)* 5.6 (20.0)* 36.3 (25.4)* 6.5 (11.2)*
B still fatigued after CBT (n = 14) pre-treatment 67.1 (27.9) 46.4 (30.8) 8.6 (17.0) 19.6 (24.4)
post-treatment 58.6 (34.6) 33.9 (38.7) 7.1 (12.7) 12.5 (19.0)
Chronic Fatigue Syndrome Patients
C non fatigued after CBT (n = 47 pre-treatment 60.4 (26.5) 42.0 (31.8) 4.7 (8.6) 20.2 (22.5)
post-treatment 11.1 (18.1)* 3.2 (8.4)* 32.3 (30.5)* 5.9 (11.9)*
D still fatigued after CBT (n = 35) pre-treatment 57.7 (30.6) 44.3 (35.9) 5.1 (11.2) 24.3 (24.6)
post-treatment 45.1 (31.2) 30.0 (33.1) 9.1 (17.0) 12.9 (15.3)*
Healthy individuals 7.7 (18.3)b,d 3.9 (13.4)b,d 36.2 (23.3)b,d 3.2 (10.2)b,d
CBT = cognitive behaviour therapy
* significant difference between pre- and post treatment scores, Wilcoxon signed rank test p < 0.01
a. significantly different from post treatment scores of group A, Mann-Whitney-U test p < 0.01
b. significantly different from post treatment scores of group B, Mann-Whitney-U test p < 0.01
c. significantly different from post treatment scores of group C, Mann-Whitney-U test p < 0.01
d. significantly different from post treatment scores of group D, Mann-Whitney-U test p < 0.01Health and Quality of Life Outcomes 2007, 5:36 http://www.hqlo.com/content/5/1/36
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study show that the FQL has adequate psychometric prop-
erties. Both the intercorrelations and the correlations of
the four factors with the subscale CIS-fatigue were not to
the extent that the factors could be seen as a parallel test,
thus supporting the relative uniqueness of each factor.
The assumption that fatigue is experienced differently by
everybody is confirmed with the data of this study.
Severely fatigued patients had different perceptions of
fatigue compared to healthy individuals. The healthy per-
sons described fatigue as temporary, relaxing, fulfilling,
normal and pleasant. None of these adjectives were cho-
sen by 70% of the severely fatigued patients. Even patients
with similar fatigue severity, appreciated fatigued differ-
ently. Different patterns were seen on the four factors of
the FQL between the different populations of patients
experiencing fatigue. CFS patients and severely fatigued
employees had the highest score on the factors Frustrat-
ing, Exhausting and Frightening and also the lowest score
on the factor Pleasant in contrast with the other fatigued
groups. Until now the underlying aetiology of CFS still
remains unclear [21,22]. Because the patients can not
attribute their fatigue to a distinct cause, it's possible that
they are more focussed on their fatigue and perceive their
fatigue in a more negative way, than the other groups. In
agreement with this finding, Moss-Morris et al. [23] found
that CFS patients had a more negative view about their
symptoms than patients with Rheumatoid arthritis (RA).
Additionally, Taillefer et al. [24] found higher levels of ill-
ness worry in CFS patients than MS patients who were
fatigued. Results of the FQL also showed that patients
with a current chronic disease experience their fatigue as
less frightening than patients with no current or a past dis-
ease. It is possible that these patients attribute their fatigue
to their illness and therefore perceive it as less frightening.
Cancer survivors may experience fatigue as highly anxiety
provoking because they can see fatigue as a symptom for
disease-recurrence. Therefore fatigue can be labelled as
frightening [25]. Future research is necessary to examine if
the FQL is applicable for individual assessment and fur-
thermore investigate what the effect of these different per-
ceptions is on the management of fatigue complaints in
the clinical practice.
To reach recovery not only a decrease in fatigue severity is
important, it is also important that a change in the evalu-
ation of fatigue in the patient occurs. As fatigue is also a
part of normal health, being recovered also includes feel-
ing tired sometimes. This makes it difficult to decide
where experiencing fatigue as a sign of illness ends and the
experience of normal health surfaces. During CBT patients
learn that fatigue may occur as part of normal healthy life.
When a decrease is seen in the fatigue severity of a patient
and the evaluation of the fatigue stays negative, it impli-
cates that a patients still suffers and is disabled due to the
fatigue. The patient cannot be seen as fully recovered [26].
The results of this study showed that the FQL can demon-
strate change in fatigue perceptions following treatment
of fatigue. Patients who were recovered after CBT had the
same scores on all four factors compared to healthy per-
sons. So, not only the fatigue severity changed after ther-
apy but also the evaluation of fatigue. The FQL can
therefore be a helpful tool to define full recovery in the
clinical practice.
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Appendix A
Fatigue quality list – FQL
Fatigue can be described in different ways. (see table 6 for
form)
Scoring FQL
Subsequently the four factors are calculated by summing
the respective items (0 – 100):    
Factor 1: Frustrating 
Table 6: Fatigue Quality List
Fatigue can be described in different ways. The adjectives below can 
be seen as descriptions of fatigue.     
Please indicate which adjectives accurately describe the fatigue you 
experienced during the last two weeks by marking them with a cross.   
upsetting persistent
discouraging frustrating
temporary relaxing
exhausting inexplicable
incessant fulfilling
wearisome insuperable
frightening unbearable
annoying normal
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Score of each item: 20  
Adjectives: discouraging, incessant, annoying, persistent,
frustrating    
Factor 2: Exhausting
Score of each item: 25  
Adjectives: exhausting, wearisome, extreme, unbearable    
Factor 3: Pleasant 
Score of each item: 20  
Adjectives: temporary, relaxing, fulfilling, normal, pleas-
ant    
Factor 4: Frightening
Score of each item: 25  
Adjectives: upsetting, frightening, inexplicable, insupera-
ble  
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